bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.47 USD
0.00 (0.43%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $0.47 0.00 (0.86%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.42 |
Last EPS Surprise | -5.00% |
ABR | 2.73 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.41 |
Next Year | -0.64 |
EPS (TTM) | -2.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.33M | 30.51M | 83.52M | 252.83M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 21.10M | 35.90M | 91.60M | 309.30M |
Low Estimate | 12.80M | 23.03M | 70.57M | 189.80M |
Year ago Sales | 12.39M | 7.83M | 29.50M | 83.52M |
Year over Year Growth Est. | 47.97% | 289.66% | 183.16% | 202.71% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.25 | -1.41 | -0.64 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.39 | -0.13 | -1.40 | -0.31 |
High Estimate | -0.29 | -0.13 | -1.08 | -0.28 |
Low Estimate | -0.46 | -0.43 | -1.71 | -1.18 |
Year ago EPS | -0.66 | -0.78 | -1.93 | -1.41 |
Year over Year Growth Est. | 42.42% | 67.95% | 26.94% | 54.72% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.25 | -1.41 | -0.64 |
7 Days Ago | -0.38 | -0.25 | -1.41 | -0.64 |
30 Days Ago | -0.38 | -0.25 | -1.42 | -0.64 |
60 Days Ago | -0.41 | -0.31 | -1.66 | -0.96 |
90 Days Ago | -0.39 | -0.32 | -1.68 | -1.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.25 | -1.71 | -0.64 |
Zacks Consensus Estimate | -0.38 | -0.25 | -1.41 | -0.64 |
Earnings ESP | 0.00% | 0.00% | -20.93% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -0.36 | -0.78 | -0.66 | NA |
Estimate | -0.40 | NA | NA | -0.69 | NA |
Difference | -0.02 | NA | NA | 0.03 | 0.01 |
Surprise | -5.00% | NA | NA | 4.35% | -0.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more